Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6548679

    Antitumor agents

    The Regents of the University of California · Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6545034

    Use of etodolac for the treatment of chronic lymphocytic leukemia

    The Regents of the University of California · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6537560

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6518247

    Method for producing an antitumoral agent and antitumoral agent thus obtained

    Obschestvo s Ogranichennoi Otvetstvennostiju “Ligpharm” · Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6512097

    High affinity human antibodies to tumor antigens

    The Regents of the University of California · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6512091

    Genetic Markers for breast, ovarian, and prostatic cancer

    The Regents of the University of California · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6511988

    Activated iododerivatives for the treatment of cancer and aids

    Isotechnika, Inc. · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6498181

    Synergistic tumorcidal response induced by histamine

    Maxim Pharmaceuticals, Inc. · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6482795

    Tumor suppressor designated TS10q23.3

    The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6482803

    Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A

    The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6479662

    Antitumor dibenzofluorene derivatives

    The Board of Regents of the University of Texas System · Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6475985

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6472369

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6470220

    Diagnosis and treatment of cancers using in vivo magnetic domains

    The Regents of the University of California · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6469184

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6451765

    Methods for treating breast cancer using Mammastatin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6451312

    VEGF-gelonin for targeting the vasculature of solid tumors

    The Board of Regents of the University of Texas System · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6426076

    Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy

    PASCO Pharmazeutische Präparate GmbH · Granted Tue Jul 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6423308

    Treatment of Kaposi's sarcoma with IL-12

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6421455

    Method for detecting cancer on skin of humans and mammals and arrangement for performing the method

    Medeikonos AB · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6419897

    Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis

    THE ARIZONA BOARD OF REGENTS · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6417338

    Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6410029

    2-methoxyestradiol-induced apoptosis in cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6406693

    Cancer treatment methods using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6395712

    Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy

    The Board of Regents of the University of Texas System · Granted Tue May 28 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6391888

    Topical anesthetics useful for treating cancer

    Regents of the University of Minnesota · Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6391554

    Detecting cancerous conditions by assaying for telomerase activity

    Geron Corporation and Board of Regents · Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6380403

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6380167

    Methods for anti-tumor therapy

    PrimeCyte, Inc. · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6376654

    Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof

    Molecular Discoveries, Inc. · Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6368596

    Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells

    The Board of Regents of the University of Texas System · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6365768

    Interleukin-1 and tumor necrosis factors-&agr; modulators, syntheses of said modulators and methods of using modulators

    The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6365797

    Mice models of human prostate cancer progression

    The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6362200

    Antitumor dibenzofluorene derivatives

    The Board of Regents of the University of Texas System · Granted Tue Mar 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6358736

    Method for increasing the antigen presenting ability of leukemia cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6355619

    Peptide tumor cell growth inhibitors

    The Board of Regents of the University of Texas System · Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6342216

    Therapy of cancer by insect cells containing recombinant baculovirus encoding genes

    The Board of Regents of the University of Texas System · Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6342392

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6331555

    Treatment of platelet derived growth factor related disorders such as cancers

    The Regents of the University of California · Granted Tue Dec 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6331284

    P202 is a tumor suppressor

    The Board of Regents of the University of Texas System · Granted Tue Dec 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6323181

    Antitumor agents

    The Regents of the University of California · Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6319496

    Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6312694

    Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6313178

    Use of hexahydrolupulones as antibacterial and anticancer agents

    Regents of the University of Minnesota · Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6306832

    Peptide antiestrogen compositions and methods for treating breast cancer

    The Regents of the University of California · Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6305380

    Method for treatment of cancer and infectious disease

    Maxim Pharmaceuticals, Inc. · Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6300308

    Methods and compositions for inducing autoimmunity in the treatment of cancers

    The Board of Regents of the University of Texas System · Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6299873

    Method for improvement of radiation therapy of malignant tumors

    UNIVERSITY OF CONNECTICUT · Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.